Clinical Trials
4 trialsNCT07180459 2025-09-18
The Treatment of Unresectable Liver Cancer With E-TACE Combined With Donafenib：A Prospective, Single-arm, Multicenter, Observational Study
The First Affiliated Hospital of Zhengzhou University
Not yet recruiting
NCT05713994 2025-03-25
CCGLC-001
Tongji Hospital
Recruiting
NCT05717738 2024-06-13
CCGLC-008
Tongji Hospital
Recruiting
NCT05205629 2022-03-23
A Real-world Study of Donafenib Combined With TACE-based Treatment in Patients With Unresectable HCC
Shanghai Zhongshan Hospital
Unknown